JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Monday, March 3, 2025

Pfizer to offer low-cost medicines, vaccines to poor nations

by

1013 days ago
20220525
A woman pushes a baby in a stroller past a sign hanging outside Pfizer headquarters in New York, Monday, May 23, 2022. Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, May 23, 2022. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots. (AP Photo/Mary Altaffer)

A woman pushes a baby in a stroller past a sign hanging outside Pfizer headquarters in New York, Monday, May 23, 2022. Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, May 23, 2022. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots. (AP Photo/Mary Altaffer)

By TOM MUR­PHY-As­so­ci­at­ed Press

 

Pfiz­er said Wednes­day that it will pro­vide near­ly two dozen prod­ucts, in­clud­ing its top-sell­ing COVID-19 vac­cine and treat­ment, at not-for-prof­it prices in some of the world’s poor­est coun­tries.

The drug­mak­er an­nounced the pro­gram at the World Eco­nom­ic Fo­rum’s an­nu­al gath­er­ing in Davos, Switzer­land, and said it was aimed at im­prov­ing health eq­ui­ty in 45 low­er-in­come coun­tries. Most of the coun­tries are in Africa, but the list al­so in­cludes Haiti, Syr­ia, Cam­bo­dia and North Ko­rea.

The prod­ucts, which are wide­ly avail­able in the U.S. and the Eu­ro­pean Union, in­clude 23 med­i­cines and vac­cines that treat in­fec­tious dis­eases, some can­cers and rare and in­flam­ma­to­ry con­di­tions. Com­pa­ny spokes­woman Pam Eise­le said on­ly a small num­ber of the med­i­cines and vac­cines are cur­rent­ly avail­able in the 45 coun­tries.

New York-based Pfiz­er will charge on­ly man­u­fac­tur­ing costs and “min­i­mal” dis­tri­b­u­tion ex­pens­es, Eise­le said. It will com­ply with any sanc­tions and all oth­er ap­plic­a­ble laws.

Ear­li­er this month, the head of the World Health Or­ga­ni­za­tion called on Pfiz­er to make its COVID-19 treat­ment more wide­ly avail­able in poor­er coun­tries. Pfiz­er has said its COVID-19 vac­cine, Comir­naty, is al­ready be­ing pro­vid­ed to poor­er coun­ties at a not-for-prof­it rate through the U.S. gov­ern­ment, which buys the shots and then dis­trib­utes them for free.

Comir­naty brought in near­ly $37 bil­lion in sales last year, and an­a­lysts ex­pect the com­pa­ny’s COVID-19 treat­ment Paxlovid to add al­most $24 bil­lion this year, ac­cord­ing to the da­ta firm Fact­Set.

 

 

COVID-19COVID-19 deathsPfizerpfizer pillCovid-19 outbreakCovid vaccinesCovid asylum


Related articles

Sponsored

Weather

PORT OF SPAIN WEATHER

Sponsored